Screening athletes for cardiovascular disease in Africa: A challenging experience

British Journal of Sports Medicine

Volumn 47, Issue 9, 2013, Pages 579-584

  Schmied, Christian ^a   Di Paolo, Fernando M ^b   Zerguini, A Yacine ^c   Dvorak, Jiri ^c   Pelliccia, Antonio ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Italian National Olympic Committee   (Italy)

^c FIFA MEDICAL CENTRE OF EXCELLENCE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANAMNESIS; ARTICLE; CARDIOLOGY; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ETHNOLOGY; EXERCISE; GABON; HEART DISEASE; HUMAN; MALE; METHODOLOGY; PHYSICAL EXAMINATION; PHYSIOLOGY; SOCCER; SUDDEN CARDIAC DEATH; YOUNG ADULT; DEATH, SUDDEN, CARDIAC; HEART DISEASES; PROCEDURES;

CARDIOLOGY;

ADOLESCENT; DEATH, SUDDEN, CARDIAC; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; GABON; HEART DISEASES; HUMANS; MALE; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; SOCCER; YOUNG ADULT;

EID: 84877695483     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2012-091803     Document Type: Article

References (39)

1. Maron BJ. Sudden death in young athletes. New Engl J Med 2003;349:1064-75.
2. Corrado D, Basso C, Rizzoli G, et al. Does sports activity enhance the risk of sudden death in adolescents and young adults ? J Am Coll Cardiol 2003;42:1959-63.
3. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-92.
4. Kimberly GH, Irfan MA, Klossner D, et al. Incidence of sudden cardiac death in National Collegiate Athletic Association Athletes. Circulation 2011;123:1594-600.
5. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Eur Heart J 2005;26:516-24.
6. Maron BJ, Thompson PD, Ackerman MJ, et al. American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. Circulation 2007;115:1643-55.
7. Pelliccia A, Di Paolo FM, Corrado D, et al. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes. Eur Heart J 2006;27:2196-200.
8. Corrado D, Basso C, Schiavon M, et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1981-9.
9. Maron BJ, Haas TS, Doerer JJ, et al. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for preparticipation screening strategies. Am J Cardiol 2009;104:276-80.
10. Baggish AL, Hutter AM Jr, Wang F, et al. Cardiovascular screening in college athletes with and without electrocardiography. A cross-sectional study. Ann Intern Med 2010;152:269-75.
11. Cappuccio FP, Cook DG, Atkinson RW, et al. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997;78:555-63.
12. Magalski A, Maron BJ, Main ML, et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol 2008; 51:2250-5.
13. Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left-ventricular remodeling in highly-trained athletes. Relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol 2008;51:2256-62.
14. Schmied C, Zerguini Y, Junge A, et al. Cardiac findings in the precompetition medical assessment of football players participating in the 2009 African Under-17 Championships in Algeria. Br J Sports Med 2009;43:716-21.
15. Papadakis M, Carre F, Kervio G, et al. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Carribbean origin. Eur Heart J 2011;32:2304-13.
16. Di Paolo FM, Schmied C, Zerguini AY, et al. The athlete's heart in adolescent Africans: electrocardiographic and echocardiographic study. J Am Coll Cardiol 2012;59:1029-36.
17. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in CARDIA study. Circulation 1995;92:785-9.
18. Maron BJ, Carney KP, Lever HM, et al. MV. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;41:974-80.
19. Ljungqvist A, Jenoure P, Engebretsen L, et al. The International Olympic Committee (IOC) Consensus Statement on periodic health evaluation of elite athletes March 2009. Br J Sports Med 2009;43:631-43.
20. Dvorak J, Grimm K, Schmied C, et al. Development and implementation of a standardized precompetition medical assessment of international elite football players - 2006 FIFA World Cup Germany. Clin J Sport Med 2009;19:316-21.
21. http://en.wikipedia.org/wiki/Gabon (accessed 7 Jul 2012).
22. Corrado D, Pelliccia A, Heidbuchel H, et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010;31:243-59.
23. Rautaharju PM, Surawicz B, Gettes LS. AHA/ACCF/HRS Recommendations for the standardization and interpretation of the ECG: Part IV: the ST segment, T and U Waves, and the QT interval. J Am Coll Cardiol 2009;53:982-91.
24. Sokolow M, Lyon TO. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37:161-86.
25. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
26. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
27. Spirito P, Maron BJ. Doppler echocardiography for assessing left ventricular diastolic function. Ann Intern Med 1988;109:122-6.
28. Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991; 324:295-301.
29. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 2006;114:1633-44.
30. Marcus F, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the task force criteria. Circulation 2010;121:1533-41.
31. Jenni R, Oechslin EN, Van der Loo B. Isolated ventricular non-compaction of the myocardium in adults. Heart 2007;93:11-15.
32. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.
33. Corrado D, Basso C, Pavei A, et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.
34. Corrado D, Basso C, Schiavon M, et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998;339:364-9.
35. Pelliccia A, Maron BJ, Culasso, et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 2000;102:278-84.
36. Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarisation abnormalities. N Engl J Med 2008;358:152-61.
37. Pelliccia A, Culasso F, Di Paolo FM, et al. Prevalence of abnormal electrocardiograms in a large, unselected population undergoing pre-participation cardiovascular screening. Eur Heart J 2007; 28:2006-10.
38. Pelliccia A, Culasso F, Di Paolo FM, et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999;130:23-31.
39. Dewey FE, Rosenthal D, Murphy DJ Jr, et al. Does size matter? Clinical applications of scaling cardiac size and function for body size. Circulation 2008; 117:2279-87.